Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Taxes on Income (Tables)

v3.23.1
Taxes on Income (Tables)
12 Months Ended
Dec. 31, 2022
Income Tax Disclosure [Abstract]  
Schedule of the domestic and foreign components
    Year ended
December 31,
 
    2022     2021     2020  
                   
Domestic   $ (40,494 )   $ (58,092 )   $ (15,625 )
Foreign    
-
     
-
     
-
 
                         
Total   $ (40,494 )   $ (58,092 )   $ (15,625 )

 

Schedule of the reconciliation of the income tax benefit
    Year ended
December 31,
 
    2022     2021     2020  
                   
Loss before income taxes, as reported in the consolidated statements of operations   $ 40,494     $ 58,092     $ 15,625  
Statutory tax rate     23 %     23 %     23 %
                         
Income tax benefit at statutory tax rate   $ (9,314 )   $ (13,361 )   $ (3,594 )
Effect of Non-deductible expenses     475       6,129       371  
Remeasurement of deferred taxes from currency exchange     3,517       209       (1,093 )
Change in valuation allowance     5,322       7,023       4,316  
                         
Reported income taxes benefit   $
-
    $
-
    $
-
 

 

Schedule of the deferred tax assets
    December 31  
    2022     2021  
Deferred tax assets:            
Net operating loss carry forwards   $ 21,991     $ 16,241  
Research and development     4,834       5,165  
Employees and payroll accrual     272       365  
Property and equipment     57       61  
                 
Total deferred tax assets     27,154       21,832  
                 
Valuation allowance     (27,154 )     (21,832 )
                 
Deferred tax assets, net of valuation allowance   $
-
    $
-